UBE2C and head and neck squamous cell carcinoma: Notably, all patients with UCS, OV, ESCA, CESC, and head and neck squamous cell carcinoma (HNSC) had amplification of the UBE2C gene, which showed an alteration frequency of ~7%, ~4%, ~3%, ~2%, and ~1%, respectively (Figure 5A).